灵灵九生物|化工原料平台|009

主页 > 生物化工 > 抑制剂 >

PURVALANOL A

中文名称:
PURVALANOL A
中文同义词:
CDK抑制剂(PURVALANOL A);(R)-2-((6-((3-氯苯基)氨基)-9-异丙基-9H-嘌呤-2-基)氨基)-3-甲基丁-1-醇;PURVALANOL A 抑制剂
英文名称:
PURVALANOL A
英文同义词:
PURVALANOL A;NG-60;6-(3-CHLOROANILINO)-2(1R)-ISOPROPYL-2-HYDROXYETHYLAMINO-9-ISOPROPYLPURINE;(2R)-2-[[6-[(3-CHLOROPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL;2-(1R-ISOPROPOYL-2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE;2-(1R-ISOPROPYL-2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYL-PURINE;CH61386;2R)-2-[[6-[(3-Chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanolCDKinhibitor.
CAS号:
212844-53-6
分子式:
C19H25ClN6O
分子量:
388.89
EINECS号:
相关类别:
小分子抑制剂,天然产物;抑制剂;小分子抑制剂;细胞生物学试剂;Inhibitors;Signalling
Mol文件:
212844-53-6.mol
沸点 
590.5±60.0 °C(Predicted)
密度 
1.33±0.1 g/cm3(Predicted)
储存条件 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解度 
methylene chloride: 50 mg/mL, clear, colorless
形态
powder
酸度系数(pKa)
14.51±0.10(Predicted)
颜色
off-white
生物活性
Purvalanol A 是一种有效的,细胞渗透性 CDK 抑制剂,对cdc2-cyclin B,cdk2-cyclin A,cdk2-cyclin E,和 cdk4-cyclin D1的 IC50 分别为 4 nM,70 nM,35 nM,和 850 nM。
体外研究
Purvalanol A decreases cell viability in dose-dependent manner in MCF-7 and MDA-MB-231 cell lines. Purvalanol A induces cell viability loss by 50 % in MCF-7 cells but MDA-MB-231 cells sre less sensitive to Purvalanol A (32 % decreases in cell viability). Purvalanol A induces mitochondria-mediated apoptosis in MCF-7 and MDA-MB-231 cells. Purvalanol A effectively prevents c-Src-mediated transformation by inhibiting both cell cycle progression and c-Src signaling, and effectively suppresses the anchorage independent growth of some human cancer cells in which c-Src is up-regulated. Purvalanol A has a stronger inhibitory effect on the anchorage-independent growth of HT29 and SW480 human colon cancer cells.
生物活性
Purvalanol A 是一种有效的,细胞渗透性 CDK 抑制剂,对cdc2-cyclin B,cdk2-cyclin A,cdk2-cyclin E,和 cdk4-cyclin D1的 IC50 分别为 4 nM,70 nM,35 nM,和 850 nM。Purvalanol A 可诱导内质网应激介导的凋亡与自噬。
靶点
Target Value Cdc2/CyclinB () 4 nM CDK2/CyclinE 35 nM CDK2/CyclinA 70 nM CDK4/CyclinD1 850 nM
Target
Value
Cdc2/CyclinB ()
4 nM
CDK2/CyclinE
35 nM
CDK2/CyclinA
70 nM
CDK4/CyclinD1
850 nM
体外研究
Purvalanol A剂量依赖性降低MCF-7和MDA-MB-231细胞系中细胞活性。Purvalanol A在MCF-7细胞中诱导50%的细胞活性损失,而MDA-MB-231细胞对Purvalanol A敏感性较低(细胞活性减少32 %)。Purvalanol A在MCF-7和MDA-MB-231细胞中诱导线粒体介导的细胞凋亡。 Purvalanol A通过抑制细胞周期进程和c-Src信号通路,有效防止c-Src介导转化,并有效抑制一些c-Src上调的人类癌细胞贴壁不依赖性生长。 Purvalanol A对HT29和SW480人结肠癌细胞的贴壁依赖性生长具有强烈的抑制作用。
WGK Germany 
3
价       格:请咨询卖家
CAS    号: 212844-53-6
规       格:10g/20g/100g/1kg
咨询电话:15623309010
正品保障
正规发票
闪电发货
满199包邮
详细介绍
英文名:
PURVALANOL A
外观:
纯度:
请咨询卖家
分子式:
C19H25ClN6O
分子量:
388.89
中文名称:
PURVALANOL A
中文同义词:
CDK抑制剂(PURVALANOL A);(R)-2-((6-((3-氯苯基)氨基)-9-异丙基-9H-嘌呤-2-基)氨基)-3-甲基丁-1-醇;PURVALANOL A 抑制剂
英文名称:
PURVALANOL A
英文同义词:
PURVALANOL A;NG-60;6-(3-CHLOROANILINO)-2(1R)-ISOPROPYL-2-HYDROXYETHYLAMINO-9-ISOPROPYLPURINE;(2R)-2-[[6-[(3-CHLOROPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL;2-(1R-ISOPROPOYL-2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE;2-(1R-ISOPROPYL-2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYL-PURINE;CH61386;2R)-2-[[6-[(3-Chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanolCDKinhibitor.
CAS号:
212844-53-6
分子式:
C19H25ClN6O
分子量:
388.89
EINECS号:
相关类别:
小分子抑制剂,天然产物;抑制剂;小分子抑制剂;细胞生物学试剂;Inhibitors;Signalling
Mol文件:
212844-53-6.mol
沸点 
590.5±60.0 °C(Predicted)
密度 
1.33±0.1 g/cm3(Predicted)
储存条件 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解度 
methylene chloride: 50 mg/mL, clear, colorless
形态
powder
酸度系数(pKa)
14.51±0.10(Predicted)
颜色
off-white
生物活性
Purvalanol A 是一种有效的,细胞渗透性 CDK 抑制剂,对cdc2-cyclin B,cdk2-cyclin A,cdk2-cyclin E,和 cdk4-cyclin D1的 IC50 分别为 4 nM,70 nM,35 nM,和 850 nM。
体外研究
Purvalanol A decreases cell viability in dose-dependent manner in MCF-7 and MDA-MB-231 cell lines. Purvalanol A induces cell viability loss by 50 % in MCF-7 cells but MDA-MB-231 cells sre less sensitive to Purvalanol A (32 % decreases in cell viability). Purvalanol A induces mitochondria-mediated apoptosis in MCF-7 and MDA-MB-231 cells. Purvalanol A effectively prevents c-Src-mediated transformation by inhibiting both cell cycle progression and c-Src signaling, and effectively suppresses the anchorage independent growth of some human cancer cells in which c-Src is up-regulated. Purvalanol A has a stronger inhibitory effect on the anchorage-independent growth of HT29 and SW480 human colon cancer cells.
生物活性
Purvalanol A 是一种有效的,细胞渗透性 CDK 抑制剂,对cdc2-cyclin B,cdk2-cyclin A,cdk2-cyclin E,和 cdk4-cyclin D1的 IC50 分别为 4 nM,70 nM,35 nM,和 850 nM。Purvalanol A 可诱导内质网应激介导的凋亡与自噬。
靶点
Target Value Cdc2/CyclinB () 4 nM CDK2/CyclinE 35 nM CDK2/CyclinA 70 nM CDK4/CyclinD1 850 nM
Target
Value
Cdc2/CyclinB ()
4 nM
CDK2/CyclinE
35 nM
CDK2/CyclinA
70 nM
CDK4/CyclinD1
850 nM
体外研究
Purvalanol A剂量依赖性降低MCF-7和MDA-MB-231细胞系中细胞活性。Purvalanol A在MCF-7细胞中诱导50%的细胞活性损失,而MDA-MB-231细胞对Purvalanol A敏感性较低(细胞活性减少32 %)。Purvalanol A在MCF-7和MDA-MB-231细胞中诱导线粒体介导的细胞凋亡。 Purvalanol A通过抑制细胞周期进程和c-Src信号通路,有效防止c-Src介导转化,并有效抑制一些c-Src上调的人类癌细胞贴壁不依赖性生长。 Purvalanol A对HT29和SW480人结肠癌细胞的贴壁依赖性生长具有强烈的抑制作用。
WGK Germany 
3
优质服务
客服电话 1562309010
正品保障 正品保障  提供发票
急速物流 现货闪电  当时发货
售后无忧 不满意退货